SCHEMBL18474334

SCHEMBL18474334

Cc1ccc2[nH]cc(C3CCCCC3)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.52
HTR1B P28222 3/20 0.50
HTR1D P28221 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
THPO P40225 1/20 0.50
OPRM1 P35372 1/20 0.49
OPRK1 P41145 1/20 0.49
OPRL1 P41146 1/20 0.49
GABRP O00591 1/20 0.48
GABRD O14764 1/20 0.48
GABRA1 P14867 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRA5 P31644 1/20 0.48
GABRA3 P34903 1/20 0.48
GABRA2 P47869 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3832948 0.86 HTR2C (0.62) IDO1HTR1BHTR1DCYP1A2CYP3A4
SCHEMBL8096608 0.86 HTR1D (0.53) IDO1HTR1BHTR1DCYP1A2CYP3A4
SCHEMBL12367411 0.85 IDO1 (0.54) IDO1HTR1BHTR1DAPPADRB2
Hydrochloric Acid SCHEMBL30375480 0.84 HTR2C (0.63) IDO1HTR1BHTR1DCYP1A2CYP3A4
SCHEMBL4674841 0.84 IDO1 (0.50) IDO1HTR1BHTR1DCYP1A2CYP3A4
SCHEMBL23010847 0.83 HTR1D (0.72) HTR1BHTR1DCYP1A2CYP3A4CYP2D6
SCHEMBL18441017 0.83 SLC6A4 (0.56) IDO1HTR1BHTR1DHTR2CSLC6A4
SCHEMBL18474204 0.83 SLC6A4 (0.56) IDO1HTR1BHTR1DHTR2CSLC6A4
SCHEMBL13849957 0.82 IDO1 (0.54) IDO1HTR1BHTR1DCYP1A2CYP3A4
SCHEMBL18622640 0.81 CYP1A2 (0.69) HTR1BHTR1DCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017023894-A1 MTHFD2 INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-02-09 WO disclosed